Ann: Market and Technology Update, page-119

I don't know what the biotech field is like to operate in. I get the feeling that it is cut throat and full of the dirtiest tricks imaginable. Neither do I know any of the board personally, but rightly or wrongly I'm prepared to wait for the results of the increased spending on advice in the corporate domain. I don't know what will turn up, but I trust that these guys will do their best.

As a speccy stock this company sure fits the bill for a rocky ride that's for sure. I don't expect all investors to have my perspective on the company. We all invested in our own ways for our own reasons. Any thoughts on the research? Do you think they have developed products at a reasonably budgeted level for such a small company or not?